FT : The best of DD’s private capital coverage in 2020

The best of DD’s private capital coverage in 2020
In the halcyon days of February 2020, private equity was having fun. 

There was fine dining, karaoke, and a private Usher concert at the industry’s SuperReturn conference in Berlin. Not to mention that €17.2bn mega-deal for Thyssenkrupp’s lifts business, one of largest leveraged buyouts in years.


But suddenly, everything changed. The coronavirus pandemic threatened to end a decade-long dealmaking boom, and highly-leveraged portfolio companies faced the bleakest economic outlook since the Great Depression. 

Meanwhile, debt financing dried up, shares in Blackstone, Apollo, Carlyle and KKR tumbled, pre-crisis deals for Amex’s business travel unit and Victoria’s Secret were called off, and the hit to portfolio companies wiped out accrued carried interest on some funds, meaning executives would stand to receive minimal performance fees if investments were realised at current valuations. 

Cinven, one of the Thyssenkrupp lifts unit buyers, struggled to sell down a stake it had bought at pre-crisis prices.

Raymond Svider, chairman of BC Partners, probably spoke for many when he told the FT in mid-March: “It feels like the world is falling apart.” 

It didn’t take the industry long to get back to aggressive manoeuvring, though. 

Silver Lake and Sixth Street Partners ploughed funds into hard-hit Airbnb, and KKR constructed a complex deal that won it the stake in cosmetics business Coty that it had been seeking for years. “Our active investment pace since the beginning of Covid has been quite intentional,” Joe Bae, co-president and co-chief operating officer of KKR, said in June. 

For Silver Lake’s Egon Durban, it was a make-or-break moment, as he bet big on the recovery of some hard-hit companies.

Silver Lake’s Egon Durban stepped in to back a number of internet companies that faced problems during the pandemic © REUTERS

Remarkably, in a year of shutdowns and a global recession, the value of private equity deals soared to its highest level since 2007. 

Enormous government stimulus packages, and sweeping central bank crisis measures, meant that in dealmaking terms, the worst global pandemic since 1918 ended up being a mere blip.

The Federal Reserve’s historic decisions to cut interest rates to zero, and buy investment grade bonds and exchange traded funds that own riskier junk debt, gave companies a lifeline — and ensured private equity’s continued access to cheap debt for new deals.


Many could also access bailout loans — after a protracted and highly controversial but ultimately successful lobbying effort, in the case of the UK — and furlough funds for portfolio companies. The idea that deep-pocketed buyout groups should be bailed out raised serious public policy questions, as did the topic of carried interest, private equity’s lucrative tax break. 

For groups such as Apollo, whose co-founder Marc Rowan had sought a hearing with the Trump administration for his ideas about how the US authorities should respond, policy responses made a huge difference. 

The dealmaking recovery paved the way for aggressive moves by individual, private equity-backed chief executives. 

Stephan Crétier, chief executive of BC Partners-backed security group GardaWorld, launched a hostile takeover bid for its far larger UK rival G4S.

EG Group founders Zuber, left, and Mohsin Issa © Jon Super/FT

In a similarly bold play, Mohsin and Zuber Issa, the brothers who run the TDR Capital-backed petrol stations business EG Group, made their most audacious acquisition yet: buying Asda from Walmart — days before Deloitte resigned as their auditor over governance concerns. 

It wasn’t all smooth sailing, though. Apollo saw investors stepping back over its founder Leon Black’s links to the late paedophile Jeffrey Epstein, while Robert Smith, the founder of Vista Equity Partners, admitted to hiding $200m from the taxman offshore and evading some $43m in taxes from 2005 to 2014. 

Meanwhile Blackstone’s Steve Schwarzman courted controversy by defending Donald Trump’s response to losing the election.

Steve Schwarzman, founder of Blackstone, has been one of Donald Trump’s most energetic supporters on Wall Street

And Silver Lake and Thoma Bravo faced embarrassment when it was reported they had sold some of their shares in IT group SolarWinds to their longtime backer, the Canada Public Pension Plan Investment Board, just days before the US issued an emergency warning that a “nation-state” hacked one of its products. 

As 2020 ends, the large listed buyout groups’ share prices have rebounded, and Blackstone and KKR are trading at all-time highs. Low interest rates have created such demand for higher-yielding debt that buyout groups are increasingly able to load companies they own with fresh loans and use the money to pay themselves dividends. 

The industry’s seemingly unstoppable momentum was capped with the news that Goldman Sachs’ top investment banker, Gregg Lemkau, was leaving to help run part of billionaire Michael Dell’s massive investment office.

Gregg Lemkau joined Goldman as an analyst in 1992 and had been seen as a potential future chief executive © Bloomberg

Of course, there’s no guarantee that the glut of 2020 deals will end up going well. But for now, the industry is back in bullish form. 

’Twas a make-or-break year for hedge funds
For years hedge fund managers have mourned the disappearance of their old friend — volatility.

The former masters of the universe, dethroned as the kings of finance by private equity groups, promised they would start to outperform once volatility was reintroduced into the market. 

Then in March, market volatility returned with a vengeance as the coronavirus pandemic engulfed the global economy. For some hedge funds, prayers had been answered. For others, it was more a case of “be careful what you wish for”. 

The Covid crisis widened the gulf in performance between hedge fund managers to levels not seen in over a decade. Some companies made so much money that nostalgic allocators were reminded of the industry’s “golden age”. 

Some of the highlights include Bill Ackman’s bet on corporate credit, which saw Pershing Square reap $2.6bn — one of the most successful trades of the year.

Bill Ackman © Bloomberg
Then there was his now-infamous interview with CNBC, where Ackman warned that “hell is coming” while funnelling his winnings back into the stock market. He has emerged as one of the biggest success stories of this year and has a similar bet going now. 

Meanwhile, some of the industry’s biggest names struggled to navigate the market chaos. Bridgewater Associates and Renaissance Technologies, both considered among the best hedge funds in the world, suffered steep losses. 

As the markets staged a recovery, stockpickers and multi-strategy funds pared back some of their losses with performance numbers turning positive. An extra boost came in November with the announcement of a vaccine and the election of Joe Biden as US president.

As well as volatile markets, there were volatile tempers. Dan Kamensky, who messaged an unnamed Jefferies executive “DO NOT SEND IN A BID” while both groups were competing to buy out securities issued by the bankrupt retailer Neiman Marcus, closed his hedge fund and could now face prosecution.

Whether market volatility was a friend or foe this year, the hedge fund industry has once again found itself at the centre of the action. 

FT : Beijing launches antitrust investigation into Alibaba

Beijing launches antitrust investigation into Alibaba
Probe into China’s biggest tech group is one of the first of its kind for country’s internet sector

China’s market regulator on Thursday announced an antitrust investigation into Alibaba, the country’s biggest tech company, a month after authorities halted sister company Ant’s $37bn initial public offering.

The investigation is one of the first of its kind into a large Chinese tech company and comes as authorities are subjecting Alibaba’s ecommerce and fintech activities to an unprecedented amount of scrutiny.

The market regulator said it was investigating suspected monopolistic practices, including Alibaba’s tactic of forcing merchants to sell exclusively on its platform, a practice known as “pick one of two” in China, among other issues.

The brief statement from China’s State Administration of Market Regulation said the investigation into Alibaba had been opened recently after complaints. Alibaba’s Hong Kong-listed shares fell more than 8 per cent in early trading.

Alibaba said it “will actively co-operate with the regulators on the investigation” and that its business operations remained normal.

In a related development, regulators led by China’s central bank said they would “supervise and guide” the group’s financial services arm, Ant Group, on issues related to fair competition and consumer protection.

In a statement, Ant confirmed that it had received a “meeting notice” from regulators and would “seriously study and strictly comply with all regulatory requirements”.

The move to investigate the country’s largest ecommerce company, which has been expanding into bricks-and-mortar retail and cloud computing, among many other new business lines, marks the most aggressive action by regulators yet to tackle the growing heft of China’s tech companies.

“This is China’s first antitrust investigation into a Chinese internet company for abusing its market dominance,” said Scott Yu, an antitrust expert at Zhong Lun law firm. “In a worst-case scenario, Alibaba could be a fined up to 10 per cent of its previous year’s sales.”

Lawyers said the initiation of a formal investigation meant the government already had some evidence to support its case.

Regulators “definitely have evidence but it is hard to say whether they will ultimately decide this constitutes monopolistic behaviour and its punishment”, said Yu Jianhua at Shanghai-based DeBund Law Offices.

After years of allowing companies such as Alibaba and its rival Tencent the freedom to grow with few restrictions, Beijing has in recent months changed tack.

“Antitrust has become an urgent issue concerning [China’s] overall situation,” the Communist Party mouthpiece People’s Daily said in an editorial on Thursday. It called the investigation “an important measure for our country to strengthen antitrust supervision of the internet sector”.

Last month, regulators released the first draft of antitrust guidelines for the internet sector, sending shares in the industry tumbling. Analysts said Alibaba had the most at stake.

The rules came soon after Alibaba and Ant founder Jack Ma made a speech in Shanghai challenging regulators and attacking state-owned banks. The speech set in motion new rules for online lenders. Many believe it also spurred regulators to cancel Ant’s Shanghai and Hong Kong initial public offering, which was set to be the world’s largest.

For years, China’s tech companies have forced merchants who want to sell on their platforms to choose which side they are on or face consequences, such as restrictions on the amount of customer traffic directed to their online shopfronts.

Last year, for example, the world’s largest microwave-oven maker, Galanz group, accused Alibaba of directing traffic away from its store on Tmall after it started selling on rival site Pinduoduo. Galanz said its sales dropped calamitously after it failed to show loyalty to Alibaba.

JD and Pinduoduo, both backed by Tencent, have also sued Alibaba for such behaviour, alleging the company abused its dominant position to prevent merchants from selling on their platforms. Alibaba previously declined to comment on the lawsuit.

As of “Singles Day” last month, China’s biggest annual online shopping event, Alibaba was still seeking to restrict merchants from working with other e-commerce platforms. While there was no explicit ban on doing so, merchants could see their page rank plummet on Taobao or Tmall after they began selling on competing platforms.

We ask Alibaba to allow merchants to freely choose which platforms to work with. Monopoly means so much to Alibaba that it wouldn't listen to us until the regulator steps in. 

In comments last week, Eric Jing, Ant chairman, said the group was “listening carefully” to criticism from regulators and consumers as it sought ways to revive its IPO.

“These are all beneficial to Ant and we have been conducting a comprehensive self-review accordingly,” Mr Jing said.

>>> What to look at today - 24th of December 2020

Most Asian stocks climbed Thursday and the pound advanced as an outline of the post-Brexit trade deal appeared to soothe investor nerves heading into the Christmas holiday period.
Shares rose in Japan and in Australia, where trading ended early for the holidays. South Korean equities outperformed. U.S. equity futures edged up after the S&P 500 finished on Wednesday just 0.1% higher. The Nasdaq Composite and Russell 2000 indexes set intraday records. Alibaba Group Holding Ltd. sank more than 8% in Hong Kong after China kicked off an investigation into alleged monopolistic practices at the tech giant.
Treasuries were steady after the gap between 5- and 30-year yields widenedWednesday to a four-year high. Volumes were subdued in many countries on Thursday. All derivatives trading is shut on Eurex and most equity markets will be closed Friday for Christmas Day.
US After Hours ALT falls -10.5% after FDA issues clinical hold on AdCOVID; MIC jumps +4.1% after declaring one-time dividend of $11/sh

Austira Closed Belgium closed @ 12:30 Denmark Closed Finland Closed France Closed @ 12:30 GErmany Closed Greece Closed Ireland Closed @2:05pm ITaly Closed Luxemburg Closed Netherlands Closed @ 12:30 Norway Closed Portugal Closed @ 12:30 Spain closed @ 2pm Sweeden Closed UK Closed @ 12:30 US Closed @ 1pm

Nikkei +0.54% Hang Seng +0.16% CSI -0.17% Shanghai -0.56% Shenzen -1.04%

Eur$ 1.2205 CNH 6.5175 CNY 6.5312 JPY 103.57 GBP 1.3556 CHF 0.8880 RUB 74.9250 TRY 7.6424 WTI$ 48.30 +0.37%

S&P +0.23% Nasdaq +0.13% EuroStoxx Closed FTSE +0.57% Dax Closed SMI Closed


Macro :
- U.S. Investor Bull-Bear Spread 21.6: AAII
- Pound Rally Sets Stage to Unwrap Final Brexit Deal: Macro Squawk

Keep an eye on :
- ABI BB : Apollo to Buy Stake in AB InBev Container Plants in $3b Deal
- AIR FP : Boeing Ramps Up 787 Checks as Undelivered Jets Stack Up: Blog
- AIR FP : GE Case Reveals Talks With Airbus Over Engine for New Jetliner
- IAG LN : U.K. to Temporarily Stop Flights, Arrivals From South Africa
- CASS IM : Cattolica Sells Its 60% Stake in Lombarda Vita to UBI Banca
- DBK GY : Ukraine to Borrow Up to $350M From Deutsche Bank by Year-End
- DOC AV : Do & Co Eyes Up to EU100m Convertibles to Fund Expansion
- EUCAR FP : Europcar Has ‘Large’ Creditor Support for Restructuring Deal
- FCA IM : U.S. Rules Mahindra 2021 Roxor Doesn’t Infringe FCA’s Rights
- MC FP : Japan’s Onward Holdings Sells Italy-Based Luxury Subsidiary:Wwd
- RI FP : Pernod Ricard: Esther Berrozpe Galindo Resigns as Director
- SQ US : Square Is Said to Have Discussed Acquiring Jay-Z’s Tidal Service
- URW NA : Maverick Capital Reduces Short Position in Unibail to 1.23%
- VIV FP : Vivendi Signs Put Option Pact to Buy Prisma Media
- VIV FP : France’s Vivendi Wins Appeal Over Berlusconi’s Mediaset Stake
- VOW GY : GM to Tout Electrifiction Drive, Battery-Powered Pickup at CES

>>> After Hours Summary: ALT falls -10.5% after FDA issues clinical hold on AdCO

After Hours Summary: ALT falls -10.5% after FDA issues clinical hold on AdCOVID; MIC jumps +4.1% after declaring one-time dividend of $11/sh

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: None

Companies trading higher in after hours in reaction to news: FFHL +8.7% (gets bid to sell its Dornier production line), HCAP +7.7% (PTMN to merge with HCAP), MIC +4.1% (declares one-time dividend of $11 per share), AFYA +2.1% (approves share buyback program), CLDR +2% (closes on $500 mln debt issuance and the repurchase of Intel's stake in the co for $314 mln), ACI +1.9% (administers first doses of vaccine and is preparing for high consumer demand, hiring pharmacy staff), MGI +1.3% (issues statement on lawsuit filed by SEC against Ripple Labs; says it has not been made aware of any negative impact to its commercial agreement with Ripple), DM +1.2% (stock offering), BUD +1.2% (APO to acquire 49.9% stake in BUD's US-based metal container plants for $3 bln), PTMN +1.1% (PTMN to merge with HCAP), FSP +1% (announces sale of property in Durham, NC), TFC +0.9% (authorizes $2 bln stock repurchase plan following Fed stress test, will maintain dividend), DS +0.7% (files for $500 mln mixed securities shelf offering), EPZM +0.2% (Boehringer Ingelheim terminates collaboration with Epizyme), X +0.2% (sells Keystone Industrial Port Complex for $160 mln), PFE +0.1% (awarded a $2.01 bln US Army contract for the production of vaccine BNT162b2), BHVN +0.1% (stock offering)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: None

Companies trading lower in after hours in reaction to news: ALT -10.5% (FDA has issued a clinical hold on its IND application for AdCOVID), DRTT -4.8% (files for $100 mln mixed securities shelf offering), VRCA -3.8% (resubmits NDA for VP-102 for the treatment of molluscum), AFMD -3.3% (files for $225 mln mixed securities shelf offering), BLU -2.9% (stock offering), TXG -1.1% (to Present at JP Morgan Healthcare Conference), TRQ -1% (evaluating tax assessment from the Mongolian Tax Authority), MRNA -0.8% (co expects its vaccine will protect against new UK Covid variant, according to CNBC tweet), UROV -0.4% (FDA approves NDA for GEMTESA), SHO -0.1% (completes a series of balance sheet enhancing transactions), TAC -0.1% (announces 6% increase to dividend, and announces sale of assets to TransAlta Renewables)

>> US Close Dow +0.38% S&P +0.07% Nasdaq -0.28% Russell +0.97%

Closing Stock Market Summary

The stock market rehashed the recovery theme for most of Wednesday's session in which value, cyclical, and small-cap stocks outperformed, but the market finished near session lows as sellers rushed for the exit before the close on no specific news. The S&P 500 finished with a 0.1% gain after being up as much as 0.7% intraday. 

The Russell 2000 (+0.9%) and Dow Jones Industrial Average (+0.4%) outperformed with the small-cap index closing above the 2000 level for the first time. The Nasdaq Composite (-0.3%) struggled all session amid relative weakness in growth stocks, which generally underperform when recovery stocks are in favor. 

The recovery trade was fueled by President Trump's insistence that Congress increase the stimulus checks to $2000 from $600, which House Democrats supported, and Pfizer (PFE 37.44, +0.70, +1.9%) and BioNTech (BNTX 100.06, -0.50, -0.5%) reaching a second agreement with the U.S. government to supply an additional 100 million doses of their COVID-19 vaccine.

The S&P 500 energy (+2.2%) and financials (+1.6%) sectors accumulated most of the gains amid higher oil prices ($48.09/bbl, +1.09, +2.3%) and curve-steepening activity caused by selling in longer-dated Treasuries. Both developments signaled an improved sentiment regarding future economic growth. 

The 2-yr yield increased one basis point to 0.13%, and the 10-yr yield increased four basis points to 0.96%. The U.S. Dollar Index decreased 0.4% to 90.34 amid relative strength in the British pound, which rose 1.0% against the dollar amid reports that an outline of a Brexit trade deal with the EU was reached.

Unfortunately, the top-weighted information technology sector (-0.9%) limited the upside in the market, as buyers preferred to focus away from the growth stocks that comprise the technology space. The real estate (-1.0%) and utilities (-0.2%) sectors slipped into negative territory during the afternoon. 

An awareness that many European markets, including Germany, will be closed tomorrow for Christmas Eve, and that the U.S. market will close early at 1:00 p.m. ET, might have exacerbated selling interest into the close. Some investors prefer to be cautious heading into extended holiday breaks.  

Separately, homebuilding stocks lagged after data showed the pace of new home sales decline 11.0% m/m to a seasonally adjusted annual rate of 841,000 ( consensus 990,000). The iShares U.S. Home Construction ETF (ITB 57.07, -0.83, -1.4%) decreased 1.4%. 

Reviewing all of Wednesday's economic data dump:

  • Personal income declined 1.1% m/m in November (consensus -0.2%), personal spending declined 0.4% (consensus -0.2%), the PCE Price Index was unchanged (consensus +0.2%) and the Core PCE Price Index was unchanged (consensus +0.2%).
    • The key takeaway for the market isn't that the income and spending data were disappointing, it's that the totality of the disappointment will reassure the market that the Fed is going to remain its friend by sticking with extraordinarily accommodative monetary policy.
  • Initial claims for the week ending December 19 decreased by 89,000 to 803,000 (consensus 860,000). Continuing claims for the week ending December 12 decreased by 170,000 to 5.337 million.
    • The key takeaway from the report is the week-over-week improvement in both initial claims and continuing claims. Both are still way too high in the big picture, yet the trend is the market's trading friend today.
  • New home sales decreased 11.0% m/m to 841,000 in November (consensus 990,000) from a downwardly revised 945,000 (from 999,000) in October. On a yr/yr basis, new home sales were up 20.8%.
    • The key takeaway from the report is that new home sales, which are counted when contracts are signed, slowed in November from a torrid recovery pace. Limited supply and rising prices had some impact, yet the strength of the market continues to be evident in the 20.8% increase in sales yr/yr.
  • New orders for durable goods increased 0.9% m/m in November (consensus 0.7%) while new orders, excluding transportation, increased 0.4% (consensus 0.5%).
    • The key takeaway for the market is that there were order increases across most categories and that business spending stayed on a positive track, evidenced by the 0.4% increase in new orders for nondefense capital goods excluding aircraft.
  • The final reading for the December University of Michigan Index of Consumer Sentiment was revised down to 80.7 from the preliminary reading of 81.4. The final reading marks an improvement from the final reading of 76.9 for November.
    • The key takeaway from the report is that consumer sentiment was improved from November, notwithstanding the reports of rising coronavirus infections and deaths, as well as the stimulus uncertainty, that prevailed during the survey period.
  • The FHFA Housing Price Index for December increased 1.5% following an unrevised 1.7% increase in November.
  • The weekly MBA Mortgage Applications Index increased 0.8% following a 1.1% increase in the prior week.

Investors will not receive any economic data on Thursday, which will be a shortened trading session for Christmas Eve. 

  • Nasdaq Composite +42.3% YTD
  • Russell 2000 +20.3% YTD
  • S&P 500 +14.2% YTD
  • Dow Jones Industrial Average +5.6% YTD

FT : South Africa Covid variant identified in Britain

South Africa Covid variant identified in Britain
Health minister says new strain may be more infectious than the one recently discovered in UK

A new coronavirus variant first detected in South Africa has been identified in the UK, the health ministry has said, as scientists warned of the risks posed by the growing number of Covid-19 mutations.

Two cases of the 501.V2 strain, which has caused a recent surge of Covid-19 infections in South Africa, have been identified in contacts of people who had arrived from the country in the past fortnight, Matt Hancock, UK health secretary, said on Wednesday.

“This virus is yet more transmissible and appears to have mutated further than the new [strain detected in the UK]”, Mr Hancock said, adding that the travellers and their close contacts must quarantine immediately.

The South African variant emerged independently from its UK counterpart, B.1.1.7, which has driven a rapid increase in Covid-19 cases across London and south-east England.

Genetic analysis shows that the UK and South African variants both have more than 20 mutations — an unusually large number of changes. Some of the mutations differ between the two strains, though some of the changes are the same.

Both variants include changes to the spike protein, which the coronavirus uses to gain entry to human cells. Scientists in South Africa have said it is “very plausible” that this N501 spike mutation may make it more infectious — perhaps because it produces a higher “viral load” in the upper respiratory tract. But they have cautioned that more study is needed.

“The preliminary data suggests that the virus that is now dominating in the second wave is spreading faster than the first wave,” said Salim Abdool Karim, the South African government’s leading Covid-19 adviser. “It is not clear if the second wave has more or less deaths, in other words, the severity is still very unclear.”

Scientists in South Africa, like their UK counterparts, are looking for evidence to show whether the new variant is likely to cause different symptoms and whether it would be harder to detect, treat or vaccinate against.

The Africa Centres for Disease Control and Prevention held an emergency meeting on Monday to discuss the 501.V2 variant, which emerged in Nelson Mandela Bay in Eastern Cape, in the south of the country. It concluded that there was no immediate need to restrict trade or travel across the continent, largely because the majority of African countries already require a negative Covid-19 test before entry.

The emergence of the new variant has coincided with what the Africa CDC called a second wave of Covid-19 in Africa, in which the number of infections and deaths has risen in some countries. It urged countries to step up testing and tracing as well as genomic sequencing to pick up the prevalence of the new strain or strains.

Like the UK — but unlike most other countries — South Africa makes an effort to track mutations of the virus through extensive genomic sequencing. British and South African scientists have suggested that this surveillance might be one reason why they have detected significant new strains that have not yet been documented in other countries.

“We are entering a particularly dangerous phase of this pandemic,” said Dr Andrew Preston, a microbiologist at the University of Bath. The evolution of two new variants at about the same time with an unusual large number of mutations makes “the effective roll-out of the vaccines even more time-critical,” he said.

FT : Dyal Capital and Owl Rock agree $12.5bn Spac tie-up

Dyal Capital and Owl Rock agree $12.5bn Spac tie-up
New group will bring together 3 companies with a combined $45bn in assets

Investment firms Dyal Capital and Owl Rock have agreed to combine in a complex deal to take them public via a blank cheque vehicle, as they seek to rival large private capital providers such as Ares Management.

Altimar Acquisition Corporation, a special purpose acquisition company set up by HPS Investment Partners, will merge with the combined entity, to be named Blue Owl Capital, thereby taking the asset managers public with a $12.5bn valuation.

As part of the deal Blue Owl will receive $1.8bn in transaction proceeds, which includes $275m raised in the Spac’s initial public offering in October and $1.5bn from blue-chip investors such as Iconiq Capital, the wealth management firm that manages money for Facebook chief Mark Zuckerberg and US conglomerate Koch Industries.

Doug Ostrover, one of Owl Rock’s founders and part of the original trio that set up Blackstone’s powerhouse credit unit, GSO Capital, will lead Blue Owl. The businesses will manage a combined $45bn in assets.

“Blue Owl’s expertise, agility and scale, supported by a substantial permanent capital base, will enable us to offer a holistic platform of capital solutions to private equity firms and privately held businesses,” Mr Ostrover said on Wednesday in a statement announcing the deal.

The unusual combination brings together three companies that are already closely intertwined. Dyal, a division of US asset manager Neuberger Berman, owns a 20 per cent stake in Owl Rock and a minority stake in HPS Investment.

Spacs have done a record amount of dealmaking this year — 158 deals have been announced over the course of 2020 with a combined value of $142bn, according to Refinitiv — but the Dyal and Owl Rock transaction is among the largest and most complex.

Founded by former Lehman Brothers bankers in 2011, New York-based Dyal has become a big player in the business of buying up general partner stakes in alternative asset managers.

The sector, which seeks to profit from management and performance fees generated by asset managers, has largely been dominated by big groups such as Goldman Sachs and Blackstone. But Dyal has raised money at a breakneck speed, with a portfolio that includes stakes in Silver Lake, Vista Equity Partners and Sixth Street Partners.

Owl Rock, on the other hand, is a direct lending specialist best known for helping to finance leveraged buyouts. The firm was set up in 2016 by veteran financiers Marc Lipschultz, Craig Packer and Mr Ostrover.